Nearly half of TP53 germline variants predicted to be pathogenic in patients with osteosarcoma are de novo: A report from the children⇔s oncology group

Brandon J. Diessner, Nathan Pankratz, Anthony J. Hooten, Lisa Mirabello, Aaron L. Sarver, Lauren J. Mills, David Malkin, Ava C. Kelley, Logan G. Spector

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Nearly half of TP53 germline variants predicted to be pathogenic in patients with osteosarcoma are de novo: A report from the children⇔s oncology group'. Together they form a unique fingerprint.

Medicine & Life Sciences